学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

安藤智暁（アンドウトモアキ）

研究テーマ	アレルギー・炎症性疾患の病態解明
研究業績（論文）	[英文誌・原著論文] ・Matsuzawa M, Ando T, Fukase S, Kimura M, Kume Y, Ide T, Izawa K, Kaitani A,Hara M, Nakamura E, Kamei A, Matsuda A, Nakano N, Maeda K, Tada N, Ogawa H,Okumura K, Murakami A, Ebihara N, Kitaura J. The protective role of conjunctival goblet cell mucin sialylation. Nat Commun. 2023 Mar 17;14(1):1417. doi: 10.1038/s41467-023-37101-y. ・Yasudo H, Ando T, Maehara A, Ando T, Izawa K, Tanabe A, Kaitani A, Nomura S, Seki M, Yoshida K, Oda H, Okamoto Y, Wang H, Kamei A, Kojima M, Kimura M, Uchida K, Nakano N, Kaneko J, Ebihara N, Hasegawa K, Shimizu T, Takita J, Ogawa H, Okumura K, Ogawa S, Tamura N, Kitaura J. A possible association between a novel NLRP1 mutation and an autoinflammatory disease involving liver cirrhosis. Hepatology. 2021. ・Yoneyama T, Nakano N, Hara M, Yamada H, Izawa K, Uchida K, Kaitani A, Ando T, Kitaura J, Ohtsuka Y, Ogawa H, Okumura K, Shimizu T：Notch signaling contributes to the establishment of sustained unresponsiveness to food allergens by oral immunotherapy. J Allergy Clin Immunol. 2020. ・Uchida S, Izawa K, Ando T, Yamada H, Uchida K, Negishi N, Kaitani A, Maehara A, Nagamine M, Kamei A, Takamori A, Maeda K, Nakano N, Shimizu T, Ogawa H, Okumura K, Nagahara A, Watanabe S, Kitaura J：CD300f is a potential therapeutic target for the treatment of food allergy. Allergy. 75: 471-474, 2020. ・Izawa K, Kaitani A, Ando T, Maehara A, Nagamine M, Yamada H, Ando T, Ide T, Matsuzawa M, Okamoto Y, Yin E, Fukase S, Wang H, Kamei A, Uchida S, Maeda K, Nakano N, Uchida K, Tamura N, Ikeda K, Ebihara N, Shimizu T, Voehringer D, Roers A, Ogawa H, Okumura K, Kitaura J：Differential lipid recognition by mouse versus human CD300f, inhibiting passive cutaneous anaphylaxis, depends on a single amino acid substitution in its immunoglobulin-like domain. J Invest Dermatol. 140: 710-713, 2020. ・Takahashi M, Izawa K, Urai M, Yamanishi Y, Maehara A, Isobe M, Matsukawa T, Kaitani A, Takamori A, Uchida S, Yamada H, Nagamine M, Ando T, Shimizu T, Ogawa H, Okumura K, Kinjo Y, Kitamura T, Kitaura J., The phytosphingosine-CD300b interaction promotes zymosan-induced, nitric oxide-dependent neutrophil recruitment., Sci Signal. 2019 Jan 15;12(564). pii: eaar5514. doi: 10.1126/scisignal.aar5514. ・Takamori A, Izawa K, Kaitani A, Ando T, Okamoto Y, Maehara A, Tanabe A, Nagamine M, Yamada H, Uchida S, Uchida K, Isobe M, Hatayama T, Watanabe D, Ando T, Ide T, Matsuzawa M, Maeda K, Nakano N, Tamura N, Ikeda K, Ebihara N, Shimizu T, Ogawa H, Okumura K, Kitaura J., Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activation., J Allergy Clin Immunol. 2019 Mar;143(3):1231-1235.e12. doi: 10.1016/j.jaci.2018.10.034. Epub 2018 Nov 9. ・Kashiwakura JI, Ando T, Karasuyama H, Kubo M, Matsumoto K, Matsuda T, Kawakami T., The basophil-IL-4-mast cell axis is required for food allergy. Allergy. 2019 Apr 21. doi: 10.1111/all.13834. ・Kaitani A, Izawa K, Maehara A, Isobe M, Takamori A, Matsukawa T, Takahashi M, Yamanishi Y, Oki T, Yamada H, Nagamine M, Uchida S, Uchida K, Ando T, Maeda K, Nakano N, Shimizu T, Takai T, Ogawa H, Okumura K, Kitamura T, Kitaura J. (2018) Sci Rep. doi: 10.1038/s41598-018-25646-8. ・Maehara A, Kaitani A, Izawa K, Shiba E, Nagamine M, Takamori A, Isobe M, Uchida S, Uchida K, Ando T, Maeda K, Nakano N, Voehringer D, Roers A, Shimizu T, Ogawa H, Okumura K, Kitamura T, Kitaura J. (2018) J Invest Dermatol. doi: 10.1016/j.jid.2017.11.025. ・Isobe M, Izawa K, Sugiuchi M, Sakanishi T, Kaitani A, Takamori A, Maehara A, Matsukawa T, Takahashi M, Yamanishi Y, Oki T, Uchida S, Uchida K, Ando T, Maeda K, Nakano N, Yagita H, Takai T, Ogawa H, Okumura K, Kitamura T, Kitaura J. (2018) The CD300e molecule in mice is an immune-activating receptor., J Biol Chem. doi: 10.1074/jbc.RA117.000696. ・Ando T, Kashiwakura JI, Itoh-Nagato N, Yamashita H, Baba M, Kawakami Y, Tsai SH, Inagaki N, Takeda K, Iwata T, Shimojo N, Fujisawa T, Nagao M, Matsumoto K, Kawakami Y, Kawakami T. (2017) Histamine-releasing factor enhances food allergy., J Clin Invest. doi: 10.1172/JCI96525. ・Nagaoka M, Yashiro T, Uchida Y, Ando T, Hara M, Arai H, Ogawa H, Okumura K, Kasakura K, Nishiyama C. (2017) The Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells., J Immunol. doi: 10.4049/jimmunol.1601911. ・Kawakami Y, Ando T, Lee JR, Kim G, Kawakami Y, Nakasaki T, Nakasaki M, Matsumoto K, Choi YS, Kawakami T. (2016) Defective natural killer cell activity in a mouse model of eczema herpeticum., J Allergy Clin Immunol. pii: S0091-6749(16)30721-7. doi: 10.1016/j.jaci.2016.06.034. ・Yasudo H., Ando T., Hiwatari M., Oka A. (2015) Suplatast tosilate for treating cutaneous mastocytosis., Pediatr Dermatol. 32(3):e118-9. ・Yasudo H., Ando T., Takeuchi M., Nakano H., Itonaga T., Takehara H., Isojima T., Miura K., Harita Y., Takita J., Oka A. (2014) Systemic lupus erythematosus complicated with liver cirrhosis in a patient with Papillon-Lefèvre syndrome, Lupus. 23(14):1523-7 ・Ando, T., Xiao, W., Gao, P., Namiranian, S., Matsumoto, K., Tomimori, Y., Hong, H., Yamashita, H., Kimura, M., Kashiwakura, JI., Hata, TR., Izuhara, K., Gurish, MF., Roers, A., Rafaels, NM., Barnes, KC., Jamora, C., Kawakami, Y., Kawakami, T. (2014) Critical Role for Mast Cell Stat5 Activity in Skin Inflammation, Cell Rep. 30;6(2):366-76. ・Ando, T., Matsumoto, K., Namiranian, S., Yamashita, H., Glatthorn, H., Kimura, M., Dolan, B. R., Lee, J. J., Galli, S. J., Kawakami, Y., Jamora, C., and Kawakami, T. (2013) Mast cells are required for full expression of allergen/SEB-induced skin inflammation, J Invest Dermatol, 133(12):2695-705. ・Kashiwakura, JC., Ando, T. (*共筆頭著者), Matsumoto, K., Kimura, M., Kitaura, J., Matho, M. H., Zajonc, D. M., Ozeki, T., Ra, C., MacDonald, S. M., Siraganian, R. P., Broide, D. H., Kawakami, Y., and Kawakami, T. (2012) Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy, J Clin Invest 122, 218-228. ・Yasudo, H., Ando, T., Xiao, W., Kawakami, Y., and Kawakami, T. (2011) Short Stat5-interacting peptide derived from phospholipase C-beta3 inhibits hematopoietic cell proliferation and myeloid differentiation, PLoS One 6, e24995. ・Xiao, W., Kashiwakura, J., Hong, H., Yasudo, H., Ando, T., Maeda-Yamamoto, M., Wu, D., Kawakami, Y., and Kawakami, T. (2011) Phospholipase C-beta3 regulates FcεRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1, Immunity 34, 893-904. ・Tomimori, Y., Kawakami, Y., McCausland, M. M., Ando, T., Koriazova, L., Kato, S., Kawakami, T., and Crotty, S. (2011) Protective murine and human monoclonal antibodies against eczema vaccinatum, Antivir Ther 16, 67-75. ・Xiao, W., Ando, T., Wang, H. Y., Kawakami, Y., and Kawakami, T. (2010) Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease, Blood 116, 6003-6013. ・Poderycki, M., Tomimori, Y., Ando, T., Xiao, W., Maeda-Yamamoto, M., Sauer, K., Kawakami, Y., and Kawakami, T. (2010) A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptor, J Immunol 184, 84-93. ・Kawakami, Y., Tomimori, Y., Yumoto, K., Hasegawa, S., Ando, T., Tagaya, Y., Crotty, S., and Kawakami, T. (2009) Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum, J Exp Med 206, 1219-1225. [英文誌・総説] ・Ando T, Kawakami T., Awaiting allograft antigen: For rejection or tolerance?, J Allergy Clin Immunol. 2019 Feb;143(2):560-562. doi: 10.1016/j.jaci.2018.11.040. Epub 2018 Dec 19. ・Kawakami, T., Ando, T., Kawakami Y. (2015) Hypothetical Atopic Dermatitis-Myeloproliferative Neoplasm Syndrome., Front Immunol., 24;6:434. ・Kawakami, T., Ando, T. (2013) Salmonella's Masterful Skill in Mast Cell Suppression, Immunity, 39(6):996-8. doi: 10.1016/j.immuni.2013.11.007. ・Kawakami, T., Ando, T., and Kawakami, Y. (2012) HRF-Interacting Molecules, The Open Allergy Journal 5, 41-46. ・Kawakami, T., Ando, T., Kimura, M., Wilson, B. S., and Kawakami, Y. (2009) Mast cells in atopic dermatitis, Curr Opin Immunol 21, 666-678. [和文誌・原著論文] ・鹿間芳明,安藤智暁,佐々木元,高橋英彦,赤城邦彦 (2011) 難治性(炎症性)疾患の病態と治療に関する研究:小児炎症性疾患における細胞表面分子の解析,こども医療センター医学誌,40 巻 3 号,248-249 ・久保田雅也,安藤智暁 (2003) Zonizamide が著効した West 症候群の 1 例, Prog Med, 23 巻 11 号, 3072-3074 [和文誌・総説] ・安藤智暁 (2016), IgE の多様性とマスト細胞, アレルギー・免疫,23 巻 12 号,1620-1628 ・安藤智暁,川上敏明 (2015) アトピー性皮膚炎におけるマスト細胞の Stat5 活性化系経路の関与, 臨床免疫・アレルギー科,63 巻 6 号,597-602 ・柏倉淳一,安藤智暁,川上敏明 (2014) アレルギー炎症と IgE Heterogeneity,化学と生物,52 巻 8 号,496-498 ・安藤智暁,川上敏明 (2013) マスト細胞と IgE:多様性が拓く治療の可能性,実験医学 ,31 巻 17 号 (増刊), 2752-2758 ・安藤智暁,川上敏明 (2013) マスト細胞活性化機構の解析から新たなアレルギー治療薬へ,化学と生物,51 巻7号,471-477 [和文・著書] ・勝呂宏,高増哲也,安藤智暁 (2007) 喘息の治療・管理のためのピークフローメーター活用ガイドブック,独立行政法人環境再生保全機構・安藤智暁 (2006) T 細胞,B 細胞とそのサブセット,小児臨床検査ガイド(五十嵐隆,水口雅編集),文光堂,pp460-466

研究テーマ

アレルギー・炎症性疾患の病態解明

研究業績（論文）

[英文誌・原著論文]
・Matsuzawa M, Ando T, Fukase S, Kimura M, Kume Y, Ide T, Izawa K, Kaitani A,Hara M, Nakamura E, Kamei A, Matsuda A, Nakano N, Maeda K, Tada N, Ogawa H,Okumura K, Murakami A, Ebihara N, Kitaura J. The protective role of conjunctival goblet cell mucin sialylation. Nat Commun. 2023 Mar 17;14(1):1417. doi:
10.1038/s41467-023-37101-y.
・Yasudo H, Ando T, Maehara A, Ando T, Izawa K, Tanabe A, Kaitani A, Nomura S, Seki M, Yoshida K, Oda H, Okamoto Y, Wang H, Kamei A, Kojima M, Kimura M, Uchida K, Nakano N, Kaneko J, Ebihara N, Hasegawa K, Shimizu T, Takita J, Ogawa H, Okumura K, Ogawa S, Tamura N, Kitaura J. A possible association between a novel NLRP1 mutation and an autoinflammatory disease involving liver cirrhosis. Hepatology. 2021.
・Yoneyama T, Nakano N, Hara M, Yamada H, Izawa K, Uchida K, Kaitani A, Ando T, Kitaura J, Ohtsuka Y, Ogawa H, Okumura K, Shimizu T：Notch signaling contributes to the establishment of sustained unresponsiveness to food allergens by oral immunotherapy. J Allergy Clin Immunol. 2020.
・Uchida S, Izawa K, Ando T, Yamada H, Uchida K, Negishi N, Kaitani A, Maehara A, Nagamine M, Kamei A, Takamori A, Maeda K, Nakano N, Shimizu T, Ogawa H, Okumura K, Nagahara A, Watanabe S, Kitaura J：CD300f is a potential therapeutic target for the treatment of food allergy. Allergy. 75: 471-474, 2020.
・Izawa K, Kaitani A, Ando T, Maehara A, Nagamine M, Yamada H, Ando T, Ide T, Matsuzawa M, Okamoto Y, Yin E, Fukase S, Wang H, Kamei A, Uchida S, Maeda K, Nakano N, Uchida K, Tamura N, Ikeda K, Ebihara N, Shimizu T, Voehringer D, Roers A, Ogawa H, Okumura K, Kitaura J：Differential lipid recognition by mouse versus human CD300f, inhibiting passive cutaneous anaphylaxis, depends on a single amino acid substitution in its immunoglobulin-like domain. J Invest Dermatol. 140: 710-713, 2020.
・Takahashi M, Izawa K, Urai M, Yamanishi Y, Maehara A, Isobe M, Matsukawa T, Kaitani A, Takamori A, Uchida S, Yamada H, Nagamine M, Ando T, Shimizu T, Ogawa H, Okumura K, Kinjo Y, Kitamura T, Kitaura J., The phytosphingosine-CD300b interaction promotes zymosan-induced, nitric oxide-dependent neutrophil recruitment., Sci Signal. 2019 Jan 15;12(564). pii: eaar5514. doi: 10.1126/scisignal.aar5514.
・Takamori A, Izawa K, Kaitani A, Ando T, Okamoto Y, Maehara A, Tanabe A, Nagamine M, Yamada H, Uchida S, Uchida K, Isobe M, Hatayama T, Watanabe D, Ando T, Ide T, Matsuzawa M, Maeda K, Nakano N, Tamura N, Ikeda K, Ebihara N, Shimizu T, Ogawa H, Okumura K, Kitaura J., Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activation., J Allergy Clin Immunol. 2019 Mar;143(3):1231-1235.e12. doi: 10.1016/j.jaci.2018.10.034. Epub 2018 Nov 9.
・Kashiwakura JI, Ando T, Karasuyama H, Kubo M, Matsumoto K, Matsuda T, Kawakami T., The basophil-IL-4-mast cell axis is required for food allergy. Allergy. 2019 Apr 21. doi: 10.1111/all.13834.
・Kaitani A, Izawa K, Maehara A, Isobe M, Takamori A, Matsukawa T, Takahashi M, Yamanishi Y, Oki T, Yamada H, Nagamine M, Uchida S, Uchida K, Ando T, Maeda K, Nakano N, Shimizu T, Takai T, Ogawa H, Okumura K, Kitamura T, Kitaura J. (2018) Sci Rep. doi: 10.1038/s41598-018-25646-8.
・Maehara A, Kaitani A, Izawa K, Shiba E, Nagamine M, Takamori A, Isobe M, Uchida S, Uchida K, Ando T, Maeda K, Nakano N, Voehringer D, Roers A, Shimizu T, Ogawa H, Okumura K, Kitamura T, Kitaura J. (2018) J Invest Dermatol. doi: 10.1016/j.jid.2017.11.025.
・Isobe M, Izawa K, Sugiuchi M, Sakanishi T, Kaitani A, Takamori A, Maehara A, Matsukawa T, Takahashi M, Yamanishi Y, Oki T, Uchida S, Uchida K, Ando T, Maeda K, Nakano N, Yagita H, Takai T, Ogawa H, Okumura K, Kitamura T, Kitaura J. (2018) The CD300e molecule in mice is an immune-activating receptor., J Biol Chem. doi: 10.1074/jbc.RA117.000696.
・Ando T, Kashiwakura JI, Itoh-Nagato N, Yamashita H, Baba M, Kawakami Y, Tsai SH, Inagaki N, Takeda K, Iwata T, Shimojo N, Fujisawa T, Nagao M, Matsumoto K, Kawakami Y, Kawakami T. (2017) Histamine-releasing factor enhances food allergy., J Clin Invest. doi: 10.1172/JCI96525.
・Nagaoka M, Yashiro T, Uchida Y, Ando T, Hara M, Arai H, Ogawa H, Okumura K, Kasakura K, Nishiyama C. (2017) The Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells., J Immunol. doi: 10.4049/jimmunol.1601911.
・Kawakami Y, Ando T, Lee JR, Kim G, Kawakami Y, Nakasaki T, Nakasaki M, Matsumoto K, Choi YS,
Kawakami T. (2016) Defective natural killer cell activity in a mouse model of eczema herpeticum., J Allergy Clin Immunol. pii: S0091-6749(16)30721-7. doi: 10.1016/j.jaci.2016.06.034.
・Yasudo H., Ando T., Hiwatari M., Oka A. (2015) Suplatast tosilate for treating cutaneous mastocytosis., Pediatr Dermatol. 32(3):e118-9.
・Yasudo H., Ando T., Takeuchi M., Nakano H., Itonaga T., Takehara H., Isojima T., Miura K., Harita Y., Takita J., Oka A. (2014) Systemic lupus erythematosus complicated with liver cirrhosis in a patient with Papillon-Lefèvre syndrome, Lupus. 23(14):1523-7
・Ando, T., Xiao, W., Gao, P., Namiranian, S., Matsumoto, K., Tomimori, Y., Hong, H., Yamashita, H., Kimura, M., Kashiwakura, JI., Hata, TR., Izuhara, K., Gurish, MF., Roers, A., Rafaels, NM., Barnes, KC., Jamora, C., Kawakami, Y., Kawakami, T. (2014) Critical Role for Mast Cell Stat5 Activity in Skin Inflammation, Cell Rep. 30;6(2):366-76.
・Ando, T., Matsumoto, K., Namiranian, S., Yamashita, H., Glatthorn, H., Kimura, M., Dolan, B. R., Lee, J. J., Galli, S. J., Kawakami, Y., Jamora, C., and Kawakami, T. (2013) Mast cells are required for full expression of allergen/SEB-induced skin inflammation, J Invest Dermatol, 133(12):2695-705.
・Kashiwakura, JC*., Ando, T.* (*共筆頭著者), Matsumoto, K., Kimura, M., Kitaura, J., Matho, M. H., Zajonc, D. M., Ozeki, T., Ra, C., MacDonald, S. M., Siraganian, R. P., Broide, D. H., Kawakami, Y., and Kawakami, T. (2012) Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy, J Clin Invest 122, 218-228.
・Yasudo, H., Ando, T., Xiao, W., Kawakami, Y., and Kawakami, T. (2011) Short Stat5-interacting peptide derived from phospholipase C-beta3 inhibits hematopoietic cell proliferation and myeloid differentiation, PLoS One 6, e24995.
・Xiao, W., Kashiwakura, J., Hong, H., Yasudo, H., Ando, T., Maeda-Yamamoto, M., Wu, D., Kawakami, Y., and Kawakami, T. (2011) Phospholipase C-beta3 regulates FcεRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1, Immunity 34, 893-904.
・Tomimori, Y., Kawakami, Y., McCausland, M. M., Ando, T., Koriazova, L., Kato, S., Kawakami, T., and Crotty, S. (2011) Protective murine and human monoclonal antibodies against eczema vaccinatum, Antivir Ther 16, 67-75.
・Xiao, W., Ando, T., Wang, H. Y., Kawakami, Y., and Kawakami, T. (2010) Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease, Blood 116, 6003-6013.
・Poderycki, M., Tomimori, Y., Ando, T., Xiao, W., Maeda-Yamamoto, M., Sauer, K., Kawakami, Y., and Kawakami, T. (2010) A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptor, J Immunol 184, 84-93.
・Kawakami, Y., Tomimori, Y., Yumoto, K., Hasegawa, S., Ando, T., Tagaya, Y., Crotty, S., and Kawakami, T. (2009) Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum, J Exp Med 206, 1219-1225.
[英文誌・総説]
・Ando T, Kawakami T., Awaiting allograft antigen: For rejection or tolerance?, J Allergy Clin Immunol. 2019 Feb;143(2):560-562. doi: 10.1016/j.jaci.2018.11.040. Epub 2018 Dec 19.
・Kawakami, T., Ando, T., Kawakami Y. (2015) Hypothetical Atopic Dermatitis-Myeloproliferative
Neoplasm Syndrome., Front Immunol., 24;6:434.
・Kawakami, T., Ando, T. (2013) Salmonella's Masterful Skill in Mast Cell Suppression, Immunity,
39(6):996-8. doi: 10.1016/j.immuni.2013.11.007.
・Kawakami, T., Ando, T., and Kawakami, Y. (2012) HRF-Interacting Molecules, The Open Allergy
Journal 5, 41-46.
・Kawakami, T., Ando, T., Kimura, M., Wilson, B. S., and Kawakami, Y. (2009) Mast cells in atopic
dermatitis, Curr Opin Immunol 21, 666-678.
[和文誌・原著論文]
・鹿間芳明,安藤智暁,佐々木元,高橋英彦,赤城邦彦 (2011) 難治性(炎症性)疾患の病態と治療に関する研究:小児炎症性疾患における細胞表面分子の解析,こども医療センター医学誌,40 巻 3 号,248-249
・久保田雅也,安藤智暁 (2003) Zonizamide が著効した West 症候群の 1 例, Prog Med, 23 巻 11 号, 3072-3074
[和文誌・総説]
・安藤智暁 (2016), IgE の多様性とマスト細胞, アレルギー・免疫,23 巻 12 号,1620-1628
・安藤智暁,川上敏明 (2015) アトピー性皮膚炎におけるマスト細胞の Stat5 活性化系経路の関与, 臨床免疫・アレルギー科,63 巻 6 号,597-602
・柏倉淳一,安藤智暁,川上敏明 (2014) アレルギー炎症と IgE Heterogeneity,化学と生物,52 巻 8 号,496-498
・安藤智暁,川上敏明 (2013) マスト細胞と IgE:多様性が拓く治療の可能性,実験医学 ,31 巻 17 号 (増刊), 2752-2758
・安藤智暁,川上敏明 (2013) マスト細胞活性化機構の解析から新たなアレルギー治療薬へ,化学と生物,51 巻7号,471-477
[和文・著書]
・勝呂宏,高増哲也,安藤智暁 (2007) 喘息の治療・管理のためのピークフローメーター活用ガ
イドブック,独立行政法人環境再生保全機構
・安藤智暁 (2006) T 細胞,B 細胞とそのサブセット,小児臨床検査ガイド(五十嵐隆,水口雅編集),文光堂,pp460-466

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

安藤 智暁（アンドウ トモアキ）

安藤智暁（アンドウトモアキ）